|
ICER announced new members for ICER’s Patient Council this week, which advises on ICER’s patient engagement strategy, outreach, and process for input into ICER assessments and broader initiatives. New members represent a wide range of patient communities, and all have participated in a recent ICER assessment. This new cohort will serve a two-year term through 2028.
Sarah K. Emond, MPP, ICER’s President and CEO stated:
“In partnership with our inaugural council, ICER’s patient engagement program has grown into what is increasingly seen as best-practice throughout the health technology assessment community. This new group of accomplished advocates will continue to build on this vital work. Their collective experience in advocating for access to treatments will inform ICER’s ever-evolving approach to incorporating patient voices into every stage of our research.”
The new members include:
-
Julie Grutzmacher, Senior Director of Patient Advocacy and Population Health Initiatives, Prevent Blindness
-
Dean Suhr, President & Co-Founder, MLD Foundation
To ensure continuity, two inaugural members will remain on the Council:
-
Tiffany Westrich-Robertson (ICER Patient Council Co-Chair), CEO, International Foundation for Autoimmune & Autoinflammatory Arthritis (AiArthritis)
-
Dina Thachet, Lupus Patient Advocate, Lupus and Allied Diseases Association (LADA)
Additionally, Catherine Koola Fischer, ICER’s Senior Director of Patient Engagement will continue as Co-Chair of the Patient Council.
|